COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
GentiBio develops engineered regulatory T-cell (EngTreg) therapies using proprietary autologous and allogeneic platforms to restore immune tolerance across autoimmune, alloimmune, autoinflammatory and allergic diseases, including Type 1 diabetes.
